baber/WOPTO huggingface dataset:
Patent CA-2467276-C (CA)
Inventor: WEILAND ANA L
IPC: H04B1/7097
Filed: 1995-12-11
Granted: 2005-06-21
Abstract: The process of the present invention adjusts the input gain by a predetermined amount. The receiver processing measures the gain change in the IF signal power.      If the change is less than the predetermined amount, the CDMA signal and jammers are below the noise floor and, therefore, the gain is increased. If the IF signal power change is equal to the predetermined amount, the CDMA signal is above the noise floor and the interference is minimal.      Therefore, in this case, gain adjustment is not necessary, but increasing gain will improve sensitivity. If the IF signal power change is greater than the predetermined amount, the interference is evident and the gain is reduced to reduce the intermodulation products. This process is used until the receiver is operating at the best compromise between interference and noise figure.
Patent CA-2467805-C (CA)
Inventor: ANDERSON MICHAEL D
IPC: A61P3/02
Filed: 2003-04-29
Granted: 2009-09-15
Abstract: L'invention concerne des complexes 1:3 de chrome (III) et d'acides alpha-aminés, ainsi que leur utilisation comme suppléments nutritionnels pour animaux.
Patent CA-2471551-C (CA)
Inventor: WILDT STEFAN
IPC: C07K14/47
Filed: 2002-12-24
Granted: 2014-09-30
Abstract: The present invention relates to host cells having modified lipid-linked oligosaccharides which may be modified further by heterologous expression of a set of glycosyltransferases, sugar transporters and mannosidases to become host-strains for the production of mammalian, e.g., human therapeutic glycoproteins. The process provides an engineered host cell which can be used to express and target any desirable gene(s) involved in glycosylation. Host cells with modified lipid-linked oligosaccharides are created or selected. N-glycans made in the engineered host cells have a GlcNAcMan3GlcNAc2 core structure which may then be modified further by heterologous expression of one or more enzymes, e.g., glycosyl-transferases, sugar transporters and mannosidases, to yield human-like glycoproteins. For the production of therapeutic proteins, this method may be adapted to engineer cell lines in which any desired glycosylation structure may be obtained.
Patent CA-2477885-C (CA)
Title: Pressurised metered dose inhalers containing solutions of beta-2 agonists
Inventor: DAVIES REBECCA JAINE
IPC: A61P11/16
Filed: 2003-02-27
Granted: 2010-12-21
Abstract: The present invention relates to a pharmaceutical formulation for use in the administration of 2(1H)-quinolinone derivatives long-acting .beta.2-agonists by inhalation. In particular this invention relates to a chemically stable highly efficient TA 2005 HFA solution formulation to be administered by pressurised metered dose inhalers (pMDIs) characterized by a deep lung penetration. The invention also relates to methods for the preparation of said formulation and to its use in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
Patent CA-2484975-C (CA)
Title: Shampoo containing a gel network
Inventor: WELLS ROBERT LEE
IPC: A61K8/895
Filed: 2003-06-04
Granted: 2010-04-20
Abstract: The compositions of the present invention relate to improved shampoo compositions having from about from about 5 to about 50 weight percent of a detersive surfactant, at least about 0.05 weight percent of a fatty alcohol gel network and at least about 20.0 weight percent of an aqueous carrier.
Patent CA-2488028-C (CA)
Inventor: MENDE RALPH
IPC: G01S13/931
Filed: 2003-07-18
Granted: 2011-11-15
Abstract: The invention relates to a sensor comprising a housing, inside of which a transmitting antenna array that transmits electromagnetic transmission signals in a radiation area and a receiving antenna array that receives received signals reflected by at least one object located within the radiation area are provided. The inventive sensor is designed in such a manner that the transmitting antenna array is provided for transmitting transmission signals in a main radiation area (3) and in a secondary radiation area (4) situated at an angle thereto, and in that the receiving antenna array (TX) is provided for receiving received signals reflected in both radiation areas (3, 4). This makes it possible, for example when used in a motor vehicle (5), to monitor the area behind and next to the motor vehicle (5) with a single transmitting antenna (1).
Patent CA-2488710-C (CA)
Inventor: NORIEGA GERARDO
IPC: A61B17/22
Filed: 2004-11-30
Granted: 2013-04-02
Abstract: A steerable coil working channel system for accessing stenosis, partial occlusions, or complete occlusions within a body lumen. The working channel system generally includes an coiled elongate member such as a hollow guidewire that can be advanced through tortuous regions in the vasculature. A deflectable distal tip is coupled to a distal end of the elongate body to facilitate directionality and positioning of the distal end of the working channel at the target site and steering the elongate body through the tortuous regions in the vasculature.
Patent CA-2495621-C (CA)
Title: Methods and apparatus for delivery of ocular implants
Inventor: REHAL MIKE
IPC: A61F9/007
Filed: 2003-09-18
Granted: 2008-02-12
Abstract: An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.
Patent CA-2502549-C (CA)
Title: Utilisation d'un dispositif de controle de l'extraction au cours d'un procede d'extraction d'acides nucleiques
Inventor: HELLYER TOBIN J
IPC: C07H21/00
Filed: 2005-04-22
Granted: 2016-02-16
Abstract: La présente invention a trait à un procédé visant à sassurer de lefficacité du traitement dextraction à partir dun échantillon biologique dacide nucléique. Le procédé selon linvention est en mesure de distinguer entre les défauts possibles dans lextraction de lacide nucléique à partir dun échantillon et des défauts possibles dans une étape damplification subséquente. La présente invention a également trait à un réseau intégré pour extraire lacide nucléique dun échantillon biologique.
Patent CA-2502921-C (CA)
Title: Fabric with three vertically stacked wefts with twinned forming wefts
Inventor: ROUGVIE DAVID S
IPC: D21F1/00
Filed: 2003-10-14
Granted: 2011-07-12
Abstract: A papermaker's fabric, usable in the forming section of a paper machine, has three layers of cross-machine-direction (CD) wefts. The forming layer wefts are grouped into pairs. This twinning of the top-layer wefts results in non-equal spacing in the forming layer. This spacing imparts a desired non-uniformity in the web-supporting surface, thereby reducing the fabric diagonal problem. One of the top-layer wefts in each pair is vertically stacked with the middle and wear side layer wefts. The other top-layer wefts in each pair are unstacked. This alignment increases the drainage properties of the fabric. The middle layer wefts provide extra stability in the CD.
Patent CA-2508406-C (CA)
Title: Interface system from pneumatic to electrically-controlled pneumatic brake systems
Inventor: TRUGLIO JAMES R
IPC: B60L/
Filed: 2003-11-26
Granted: 2008-03-18
Abstract: An interface system (10) includes locomotive and car electrical trainline terminals (18, 19), locomotive and car brake pipe ports (12, 14) and a locomotive pressure supply port (16). A train brake pipe valve (28) controls pressure on the train brake pipe port (14). A controller (60) monitors pressure on the locomotive brake pipe port (12) and controls the train brake pipe valve (28) in response to pressure on the locomotive brake pipe port (12). The controller (60) also provides ECP commands on the train electrical terminal (19) in response to pressure on the locomotive brake pipe port (12) and provides electrical power on the train terminal from the locomotive electrical trainline terminal (18). The car electrical terminal (19) is connected to the ECP trainline (108) for providing ECP commands and power to the ECP equipped train devices. The controller may also control an emergency valve (50) to produce an emergency signal on the locomotive brake pipe port (12). A transition valve (94) on the brake pipe port allows bi-directional connection of the interface system.
Patent CA-2511822-C (CA)
Inventor: HOUZE DAVID
IPC: B65D75/52
Filed: 2003-12-29
Granted: 2011-06-28
Abstract: L'invention concerne un emballage de produit à dispositif de rétention (10) formant une cavité interne étanche (16) qui reçoit le produit (18), en particulier du type: systèmes de délivrance transdermique, pansements, bandages, films, feuilles, etc. Un dispositif de rétention (20,26) est établi en association avec la cavité pour maintenir le produit en position distale par rapport à un point d'ouverture prédéterminé (22). En contrôlant cette position dans l'emballage, l'utilisateur ouvre avec une facilité et une sécurité accrues l'emballage en son point d'ouverture sans endommager le produit.
Patent CA-2515388-C (CA)
Title: Sintered adsorbents, preparation method thereof and use of same for the drying of organic compounds
Inventor: PLEE DOMINIQUE
IPC: B01D53/28
Filed: 2004-02-10
Granted: 2009-01-20
Abstract: The invention relates to sintered molecular sieves based on molecular sieves with pore openings equal to approximately 3 .ANG., to the preparation method thereof and to the use of same for the drying of organic compounds, particularly alcohols and/or esters, in gaseous or liquid phase, whereby compounds to be dehydrated are passed through an adsorbent bed based on the aforementioned sintered sieves.
Patent CA-2516519-C (CA)
Inventor: BELIEN ANN TRUDO JOSEE
IPC: C12N/
Filed: 2004-03-03
Granted: 2013-09-17
Abstract: In a first aspect the present invention provides a tumor cell line stably transfected with an expression vector containing a reporter gene, preferably a fluorescent protein, operably linked to a promotor that also controls expression of a protein that is associated with tumor regression, stabilisation of tumor growth or inhibition of metastatic growth, characterised in that said cell line is capable to form a tumor when implanted or injected into the non-human animal. Compared to the traditional in vivo models, the present invention differs in that the reporter gene is not constitutively expressed, but only after exposure to a test compound that results in the expression of a protein or enzyme associated with tumor regression, stabilisation of tumor growth or inhibition of metastatic growth. Only when a compound to be tested got into circulation and infiltrated the tumor it may generate the reporter signal, provided it promotes the expression of a protein associated with tumor regression and the promoter of said protein is operably linked to the reporter gene.
Patent CA-2526809-C (CA)
Title: High-damage tolerant aluminium alloy product in particular for aerospace applications
Inventor: HARGARTER HINRICH JOHANNES WILHELM
IPC: B64C3/26
Filed: 2004-06-03
Granted: 2012-11-13
Abstract: The invention relates to an aluminium alloy wrought product with high strength and fracture toughness and high fatigue resistance and low fatigue crack growth rate, and having a composition of (in wt.%): 0.3 to 1.0 % Mg, 4.4 to 5.5% Cu, 0 to 0.20% Fe, 0 to 0.20% Si, 0 to 0.40% Zn, and Mn in a range 0.15 to 0.8 as dispersoids forming element in combination with one or more of dispersoids forming elements selected from the group consisting of: Zr, Sc, Cr, Hf, Ag, Ti, V, the balance being aluminium (Al) and other incidental elements, and whereby there is a limitation of the Cu-Mg content such that: -1.1[Mg]+5.38<= [Cu]<= 5.5. The invention further relates to a method of manufacturing such a product.
Patent CA-2530715-C (CA)
Title: Method and apparatus for implementing a sleep proxy for services on a network
Inventor: CHESHIRE STUART D
IPC: H04L12/40
Filed: 2004-04-29
Granted: 2009-12-29
Abstract: One embodiment of the present invention provides a system for implementing a sleep proxy. The system starts by receiving a request at the sleep proxy for information pertaining to a service provided by a device. In response to this request, the system determines if the device is a member of a list of devices for which the sleep proxy takes action. If so, the system determines if the sleep proxy can answer the request. If so, the sleep proxy sends a response to the request on behalf of the device. In a variation on this embodiment, if the system cannot answer the request on behalf of the device, the system sends a wakeup packet to the device, wherein the wakeup packet causes the device to exit a power-saving mode so that the device can respond to the request directly.
Patent CA-2534351-C (CA)
Inventor: NABEL GARY J
IPC: C07K14/08
Filed: 2004-08-02
Granted: 2018-10-02
Abstract: The present invention relates to genetic vaccines for stimulating cellular and humoral immune responses in humans and other hosts, and, in particular, relates to recombinant viruses that express heterologous antigens of pathogenic viruses, in single dose form.
Patent CA-2534933-C (CA)
Inventor: BARTHELET PHILIPPE
IPC: H04W88/02
Filed: 2006-02-01
Granted: 2015-03-31
Abstract: The invention relates to a portable communication device with an external housing (1) containing at least a mechanical switch (2a; 2b) and at least one key (3) for actuation of said mechanical switch (2a; 2b), said key comprising an actuation surface (30) which protrudes from said external housing through an aperture (10), and the mechanical switch being able to be actuated by swiveling of the key (3) around an axis (XX') substantially perpendicular to said actuation surface. According to the invention said key is made of plastic material and comprises, in its thickness and behind said actuation surface, at least one emerging slit (31a; 31b) extending substantially parallel to said actuation surface.
Patent CA-2547188-C (CA)
Inventor: HOLZHAUER THOMAS
IPC: B21C47/00
Filed: 2004-10-27
Granted: 2010-12-14
Abstract: The invention relates to a reel driving device for rolling mills, said device comprising an upper driving roll (1') and a lower driving roll (1). The aim of the invention is to improve said reel driving device in such a way that the rolled product is not damaged by the rolls (1, 1'), that the rolled product does not adhere to the rolls (1, 1'), and that the driving rolls (1, 1') can be economically created as standard expendable parts. To this end, the lower driving roll (1) comprises a steel roll axle (2) to which a cast envelope (3) adheres and/or onto which said cast envelope is shrunk and/or the upper driving roll (1') comprises a cast envelope (3') held between two clamping elements (5) arranged on an axle (2').
Patent CA-2555943-C (CA)
Inventor: LEAH ROBERT
IPC: H01M8/04
Filed: 2005-02-02
Granted: 2011-09-13
Abstract: L'invention concerne un procédé et un dispositif pour le fonctionnement d'un assemblage de piles à combustible à oxyde solide en température intermédiaire (10) avec un électrolyte à conduction mixte ionique/électronique, visant à augmenter l'efficacité. On détermine la sortie d'énergie requise de l'assemblage (10) puis on contrôle une ou plusieurs conditions de fonctionnement de cet assemblage (10) en fonction de la valeur de sortie ainsi déterminée. Les conditions de fonctionnement contrôlées peuvent être au moins la température de l'assemblage ou la dilution du combustible fourni à l'assemblage.
Patent CA-2556870-C (CA)
Inventor: BARBERICH TIMOTHY J
IPC: A61K45/06
Filed: 2005-02-07
Granted: 2014-01-28
Abstract: The present invention generally to pharmaceutical compositions comprising a dopamine agonist and sedative agent. In a preferred embodiment, the dopamine agonist is optically pure (S)-didesmethylsibutramine. In a preferred embodiment, the sedative agent is optically pure (S)-zopiclone or optically pure (S)-N-desmethylzoplicone. The pharmaceutical compositions of the invention are useful in the treatment of restless-leg syndrome and periodic-limb-movement disorder, as well as various sleep disorders.
Patent CA-2558678-C (CA)
Inventor: EDWARDS RUSSELL J
IPC: B65B57/14
Filed: 1995-06-08
Granted: 2010-03-23
Abstract: An automated apparatus for controlling the automatic packaging of contact lenses in a contact lens fabrication facility. A first robotic transfer device is provided for periodically transferring a first predetermined amount of individual packages from the first station to an intermediate consolidation buffer. The packages are deposited on the consolidation buffer. A controller tracks down and identifies each individual contact lens conveyed form an inspection station to the consolidation buffer. The controller includes a memory and a logic for storing the identity of individual packages containing contact lenses, predetermined as out of specification by the inspection station, and generates a signal to cause the first robotic device to discard any individual package identified by the controller as being out of specification. A second robotic assembly periodically transfers a second predetermined amount of individual packages from the consolidation buffer to a second processing station. The controller enables the first robotic device to provide sufficient amount of individual packages to the consolidation buffer to enable the second robotic assembly to continuously transfer the second predetermined amount of packages to the second processing station in every period.
Patent CA-2562311-C (CA)
Title: Protege-drap lavable et procede de production de celui-ci
Inventor: GOYARTS GREGORIUS MARIA HUBERTUS
IPC: A61F13/515
Filed: 2004-04-02
Granted: 2012-10-16
Abstract: L'invention concerne une matière lavable multicouche qui comprend au moins une couche d'une matière textile, les couches étant reliées les unes aux autres au moyen d'une composition adhésive. Cette matière est caractérisée en ce que la zone interfaciale entre chaque paire de couches se touchant consiste en une composition adhésive en forme de motif, et un non fini de la matière multicouche, tel que et/ou une partie inférieure obtenue à partir de celle-ci étant mise en oeuvre. Un exemple d'une matière lavable multicouche de ce type consiste en un protège-drap lavable comprenant une matière en couche supérieure perméable à la moisissure (2), une matière de couche inférieure imperméable à la moisissure (3) et un élément d'absorption de la moisissure (1) placés entre eux, la matière de couche supérieure (2), la matière de couche inférieure (3) et l'élément d'absorption de moisissure (1) étant reliés entre eux. L'invention concerne également un procédé de production d'une matière multicouche lavable de ce type, dans laquelle une composition adhésive est appliquée dans la zone interfaciale devant être formée entre la matière de couche supérieure (2) et la matière intercouche (1) et dans la zone interfaciale devant être formée entre la matière de couche inférieure (3) et la matière intercouche (1), les couches étant amenées à se toucher et étant reliées au moyen des couches d'une composition adhésive appliquée sous forme de motif, et un non fini de matière multicouche tel que et/ou une partie inférieure coupée dans cette matière étant mise en oeuvre. La composition adhésive utilisée consiste de préférence en une matière fondue à chaud de polyuréthanne réactif qui durcit à l'humidité.
Patent CA-2563525-C (CA)
Title: Inhibiting effects of sloughing in wellbores
Inventor: BAI TAIXU
IPC: E21B43/24
Filed: 2005-04-22
Granted: 2012-07-17
Abstract: The invention provides a method for treating a subsurface formation. The method includes providing one or more explosives into portions of one or more wellbores selected for the explosion in the formation. The wellbores formed are in one or more zones in the formation. The method also includes controllably exploding the explosives in one or more of the wellbores such that at least some of the formation surrounding the selected wellbores has an increased permeability. The method also includes providing one or more heaters in the one or more wellbores.
Patent CA-2563607-C (CA)
Inventor: MAYNARD GEORGE D
IPC: C07D401/04
Filed: 2005-05-06
Granted: 2014-04-08
Abstract: 4,5-disubstituted-2-arylpyrimidines of Formula (I) and Formula (II) are provided: wherein R1, R2, R3, R8, R9, A and Ar are defined herein. Such compounds are ligands of C5a receptors. Preferred compounds of Formula I and II bind to C5a receptors with high affinity and exhibit neutral antagonist or inverse activity at C5a receptors. The present invention also relates to pharmaceutical compositions comprising such compounds, and to the use of such compounds in treating a variety of inflammatory, cardiovascular, and immune system disorders. In addition, the present invention provides labeled 4,5-disubstituted-2-arylpyrimidines, which are useful as probes for the localization of C5a receptors.
Patent CA-2564684-C (CA)
Title: Use of thioxanthene derivatives as chemosensitising compounds
Inventor: BIRGIT KJAELDGAARD GIWERCMAN
IPC: A61K31/5415
Filed: 2005-04-29
Granted: 2010-10-26
Abstract: The present invention is directed to the use of chemosensitising compounds, in particular thioxanthene derivatives and phenothiazine derivatives, for treatment of infectious diseases in combination with an anti-infective agent.  The invention furthermore relates to compositions comprising said chemosensitising compounds and anti-infective agents.
Patent CA-2565039-C (CA)
Inventor: MASUDA YUTAKA
IPC: A23P30/40
Filed: 2005-04-11
Granted: 2013-01-29
Abstract: An alcoholic beverage that as it has fluidity at -15° to -2°C, can be drunk easily and appropriately and that through coexistence of fine ice pieces and bubbles, induces novel pleasant sensation of coolness and coldness and feeling of swallow, appropriate sensation of alcohol, and excellent flavor. There is provided an alcoholic beverage characterized in that it is produced by mixing an alcoholic beverage base mix containing alcohol and at least one type of water-soluble substance with ice pieces in a proportion of 20:80 to 80:20, and conducting aeration, agitation and cooling so that the volume fraction of contained gas is in the range of 1 to 150% and that the mixture temperature is lower than -1 °C, thereby obtaining a gas-containing matter having an alcohol concentration of >= 1.0 vol.% and being fluid at -15° to -2°C wherein fine ice pieces of 0.06 to 0.8 mm major axis length are present in an amount of at least 80 wt.% based on the total weight so that remaining of at least part of the fine ice pieces is sensed.
Patent CA-2565382-C (CA)
Inventor: AGERUP BENGT
IPC: A61P27/06
Filed: 2005-05-04
Granted: 2013-12-03
Abstract: A viscoelastic medium is useful for the manufacture of a medicament, such as a medical device, for treatment of increased intraocular pressure in the eye of a human or an animal. The medicament is administrable into at least one sclerally penetrating fistula of the eye such that the fistula is filled with the medicament. The medium is also useful in a method of treating increased intraocular pressure in the eye of a human or an animal in need thereof, comprising the step of injecting the viscoelastic medium into at least one sclerally penetrating fistula in the eye such that the fistula is filled with the medium.